Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Woodward Pharma Services.

    Client Virtual Booth

    WOODWARD PHARMA SERVICES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    SERVICES

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Woodward Pharma Services
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    770 S. Adams Road, Suite 101, Birmingham, MI 48009
    Telephone
    Telephone
    248.308.1120
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.woodwardpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/9458417/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    A.forall Announces Launch of a Generic Version of Sodium Acetate Injection 4 mEq/mL

    Details:

    Sodium Acetate-generic Injection 4 mEq/mL is indicated as a source of sodium for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake.


    Lead Product(s): Sodium Acetate

    Therapeutic Area: Nephrology Product Name: Sodium Acetate-Generic

    Highest Development Status: ApprovedProduct Type: Small molecule

    Recipient: Milla Pharmaceuticals

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable January 09, 2024

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Woodward Pharma Services LLC Acquires LOVAZA(R) Capsules

    Details:

    Woodward Pharma Services LLC, has acquired Lovaza (LO-VEY-ZA) soft gelatin capsules indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe (greater than or equal to 500 mg/dL) hypertriglyceridemia from GlaxoSmithKline LLC (GSK).


    Lead Product(s): Omega-3-Acid Ethyl Esters 90

    Therapeutic Area: Cardiology/Vascular Diseases Product Name: Lovaza

    Highest Development Status: ApprovedProduct Type: Small molecule

    Recipient: GSK

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Acquisition August 18, 2021

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search